Invesco Dorsey Wright Healthcare Momentum ETF
Invesco Exchange-Traded Fund Trust
+38
New
38
Positions
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Apr 2025 | 25,531,198 | $25.5M | 23.48% | STIV |
| 2 | Invesco Private Government Fund | N/A | Apr 2025 | 9,815,269 | $9.8M | 9.03% | STIV |
| 3 | Cencora, Inc. | 03073E105 | Apr 2025 | 15,892 | $4.7M | 4.28% | EC |
| 4 | Eli Lilly and Co. | 532457108 | Apr 2025 | 5,160 | $4.6M | 4.27% | EC |
| 5 | TG Therapeutics, Inc. | 88322Q108 | Apr 2025 | 98,264 | $4.5M | 4.11% | EC |
| 6 | Exelixis, Inc. | 30161Q104 | Apr 2025 | 112,750 | $4.4M | 4.06% | EC |
| 7 | Boston Scientific Corp. | 101137107 | Apr 2025 | 38,756 | $4.0M | 3.67% | EC |
| 8 | Alignment Healthcare, Inc. | 01625V104 | Apr 2025 | 216,273 | $3.8M | 3.52% | EC |
| 9 | BridgeBio Pharma, Inc. | 10806X102 | Apr 2025 | 98,763 | $3.8M | 3.48% | EC |
| 10 | Guardant Health, Inc. | 40131M109 | Apr 2025 | 79,520 | $3.8M | 3.45% | EC |
| 11 | Axsome Therapeutics, Inc. | 05464T104 | Apr 2025 | 32,050 | $3.6M | 3.31% | EC |
| 12 | Krystal Biotech, Inc. | 501147102 | Apr 2025 | 21,179 | $3.6M | 3.31% | EC |
| 13 | Madrigal Pharmaceuticals, Inc. | 558868105 | Apr 2025 | 10,699 | $3.6M | 3.29% | EC |
| 14 | ResMed Inc. | 761152107 | Apr 2025 | 14,971 | $3.5M | 3.26% | EC |
| 15 | Insmed Inc. | 457669307 | Apr 2025 | 47,875 | $3.4M | 3.17% | EC |
| 16 | AbbVie Inc. | 00287Y109 | Apr 2025 | 17,457 | $3.4M | 3.13% | EC |
| 17 | Merit Medical Systems, Inc. | 589889104 | Apr 2025 | 33,351 | $3.2M | 2.90% | EC |
| 18 | Lantheus Holdings, Inc. | 516544103 | Apr 2025 | 30,140 | $3.1M | 2.89% | EC |
| 19 | Trevi Therapeutics, Inc. | 89532M101 | Apr 2025 | 431,965 | $3.0M | 2.74% | EC |
| 20 | Protagonist Therapeutics, Inc. | 74366E102 | Apr 2025 | 64,510 | $3.0M | 2.72% | EC |
| 21 | 908 Devices Inc. | 65443P102 | Apr 2025 | 538,908 | $2.9M | 2.69% | EC |
| 22 | Catalyst Pharmaceuticals, Inc. | 14888U101 | Apr 2025 | 117,101 | $2.8M | 2.62% | EC |
| 23 | uniQure N.V. | N90064101 | Apr 2025 | 190,447 | $2.8M | 2.58% | EC |
| 24 | Ocular Therapeutix, Inc. | 67576A100 | Apr 2025 | 335,069 | $2.8M | 2.56% | EC |
| 25 | PTC Therapeutics, Inc. | 69366J200 | Apr 2025 | 55,529 | $2.8M | 2.55% | EC |
| 26 | Arcutis Biotherapeutics, Inc. | 03969K108 | Apr 2025 | 176,977 | $2.6M | 2.43% | EC |
| 27 | Masimo Corp. | 574795100 | Apr 2025 | 16,211 | $2.6M | 2.40% | EC |
| 28 | Axogen, Inc. | 05463X106 | Apr 2025 | 156,421 | $2.5M | 2.34% | EC |
| 29 | Amneal Pharmaceuticals, Inc. | 03168L105 | Apr 2025 | 329,608 | $2.5M | 2.32% | EC |
| 30 | agilon health, Inc. | 00857U107 | Apr 2025 | 551,528 | $2.3M | 2.16% | EC |
| 31 | Halozyme Therapeutics, Inc. | 40637H109 | Apr 2025 | 38,197 | $2.3M | 2.16% | EC |
| 32 | Anavex Life Sciences Corp. | 032797300 | Apr 2025 | 245,545 | $2.3M | 2.15% | EC |
| 33 | Organogenesis Holdings Inc. | 68621F102 | Apr 2025 | 446,741 | $2.2M | 2.02% | EC |
| 34 | Xeris Biopharma Holdings, Inc. | 98422E103 | Apr 2025 | 464,966 | $2.1M | 1.95% | EC |
| 35 | Liquidia Corp. | 53635D202 | Apr 2025 | 145,098 | $2.0M | 1.86% | EC |
| 36 | Mineralys Therapeutics, Inc. | 603170101 | Apr 2025 | 140,029 | $2.0M | 1.83% | EC |
| 37 | Phreesia, Inc. | 71944F106 | Apr 2025 | 76,448 | $1.9M | 1.75% | EC |
| 38 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 249,261 | $249K | 0.23% | STIV |